Researchers in California, using a mouse model, have found three new formulations that could be used in a vaccine to treat addiction to methamphetamine.
The formulations produce a good immune response in the mice, UPI reports. Methamphetamine is highly addictive, and users in behavioral treatment programs often relapse, according to a news release by the Scripps Research Institute, where the research was conducted. The researchers note meth vaccines that have been previously tested were not effective or were very expensive.
The new vaccine formulations potentially could be effective for longer periods than previous vaccines, which could lead to lower costs and reduced risk of relapse.
The study appears in the Journal of the American Chemical Society.